INS and Decreased liver function: In the double-blind, randomized study of 40 obese, insulin-resistant volunteers, the three months of oral administration of the pasteurized bacteria A. muciniphila (1010 CFU) resulted in reduced levels of the relevant blood markers of liver dysfunction and inflammation, improved insulin sensitivity, and slightly decreased body weight [88].